Table 3.
IFN-γ (ng/ml) | 0 | 20 | 40 | 80 |
---|---|---|---|---|
CD4+CD25+ (%) | 32.8 ± 3.2** | 55.2 ± 3.7* | 54.1 ± 4.1* | 42.8 ± 2.9*,** |
*P < 0.05 vs. 0 ng/mL IFN-γ induced CD4+CD25+ (%). **P < 0.05 vs. 20 ng/mL IFN-γ induced CD4+CD25+ (%)
IFN-γ (ng/ml) | 0 | 20 | 40 | 80 |
---|---|---|---|---|
CD4+CD25+ (%) | 32.8 ± 3.2** | 55.2 ± 3.7* | 54.1 ± 4.1* | 42.8 ± 2.9*,** |
*P < 0.05 vs. 0 ng/mL IFN-γ induced CD4+CD25+ (%). **P < 0.05 vs. 20 ng/mL IFN-γ induced CD4+CD25+ (%)